期刊文献+

黏蛋白在肾透明细胞癌中的表达及意义

The mucin 1 expression in renal clear cell carcinoma and its clinical significance
下载PDF
导出
摘要 目的:探讨黏蛋白1(MUC1)在人肾透明细胞癌中的表达及意义。方法:采用免疫组织化学SP法检测57例肾透明细胞癌(RCCC组)和21例肾癌旁组织(对照组)中MUC1的表达。应用Image-Pro Plus 6.0型图像分析软件定量测定阳性染色区的平均吸光度值。结果:MUC1定位表达于细胞质中,肾癌细胞和癌旁组织中均有表达,RCCC组平均吸光度值为0.429 5±0.093 9,对照组为0.337 1±0.082 2,差异有统计学意义(P<0.01)。MUC1表达与肾癌的临床分期及有无转移均有一定关系(P<0.01和P<0.05)。结论:MUC1在人肾透明细胞癌中表达增强,可能在人肾透明细胞癌的发生、发展、浸润及转移中起重要作用,可能成为肾癌免疫治疗的靶抗原。 Objective: To investigate the mucin 1( MUC1) expression in renal clear cell carcinoma and its clinical significance.Methods: The MUC1 expressions of renal clear cell carcinoma( RCCC) tissue in 57 cases( RCCC group) and paracancerous tissue in21 cases( paracancerous group) were detected by immunohistochemical method. The average optical density( OD) value in positive staining area was measured by Image-Pro Plus 6. 0 analysis software. Results: The MUC1 expressions in cytoplasm of renal cancer cells and paracancerous tissue were found. The average OD value in RCCC group and paracancerous group were 0. 429 5 ± 0. 093 9 and0. 337 1 ± 0. 082 2,respectively,the difference of which was statistical significance( P〈0.01). The MUC1 expression was correlated with the clinical stage and metastasis of RCCC( P〈0.01 and P〈0.05). Conclusions: The high level expression of MUC1 may play important roles on the occurrence,progression,invasion and metastasis in RCCC,which may be a target antigen in the immunotherapy of renal carcinoma.
出处 《蚌埠医学院学报》 CAS 2014年第10期1353-1355,共3页 Journal of Bengbu Medical College
关键词 肾肿瘤 肾透明细胞癌 黏蛋白1 免疫组织化学 kidney neoplasms renal clear cell carcinoma mucin 1 immunohistochemistry
  • 相关文献

参考文献9

  • 1Rahagani S,Torres MP,Moniaux N,et al.Cuttent status of mucins in the diagnosis and therapy of cancer[J].Biofactors,2009,35(6):509-527.
  • 2Von Mensdorf Pouilly S,Snijdewint FG,Verstraeter AA,et al.Human MUC1 mutin:a multifaceted glyciprotein[J].Int J Biol Markers,2000,15(4):343-356.
  • 3李威武,李培军,张宁妹,秦璟.MUC1在肾癌中的表达及意义[J].宁夏医学杂志,2009,31(6):511-512. 被引量:1
  • 4Ren J,Li Y,Kufe D.Protein kinase C delta regulates function of the DF3/MUC1 carcinoma antigen in β-catenin signaling[J].J Biol Chem,2002,277(20):17616-17622.
  • 5Kraus S,Abel PD,Nachtmann C,et al.MUC1 mucin and trefoil factor protein expression in renal cell carcinoma:correlation with prognosis[J].Hum Pathol,2002,33(1):60-67.
  • 6Yuan Z,Wong S,Borrelli A,et al.Down-regulation of MUC1 in cancer cells inhibits cell migration by promoting E-cadherin/catenin complex formation[J].Biochem Biophys Res Commun,2007,362(3):740-746.
  • 7Thirkill TL,Cao T,Stout M,et al.MUC1 is involved introphoblast transendothelial migration[J].Biochim Biophys Acta,2007,1773(6):1007-1014.
  • 8袁时芳,师长宏,晏伟,王廷,韩苇,王岭,张英起,窦科峰.人MUC1重复序列与GM—CSF融合表达的重组卡介苗疫苗对乳腺癌生长的抑制作用[J].中华普通外科杂志,2011,26(8):677-682. 被引量:3
  • 9吴文川,靳大勇,楼文晖,戎叶飞,王单松,秦新裕.新型胰腺癌MUC1DNA疫苗的免疫原性研究[J].中华肝胆外科杂志,2013,19(3):212-214. 被引量:2

二级参考文献22

  • 1吴文川,靳大勇,秦新裕,楼文晖,王单松,倪晓凌,吴肇汉.胰腺癌MUC1-VNTR核酸疫苗的构建和体外转染[J].中华实验外科杂志,2005,22(9):1081-1083. 被引量:9
  • 2吴文川,靳大勇,秦新裕,楼文晖,王单松,倪晓凌,吴肇汉.建立胰腺癌黏液蛋白核芯肽-连续重复序列核酸疫苗的实验研究[J].中华普通外科杂志,2006,21(5):357-359. 被引量:7
  • 3Storkel S, Eble JN, Adlakha K, et al. Classification of renal cell carcinoma[ J]. Cancer, 1997,80:987 - 989.
  • 4AJCC Cancer Staging Manual [ M ]. Sixth ed. New Youk: Springer Verlag, 2002.
  • 5Leroy X, Copin M C, Devisme L, et al. Expression of human mucin genes in normal kidney and renal cell carcinoma[J]. Histopathology,2002 ,40 (5) :450 - 457.
  • 6Leroy X, Zerimech F, Zini L, et al. MUC1 expression is correlated with nuclear grade and tumor progression in pT1 renal clear cell carcinoma[J]. Am J Clin Pathol, 2002 ,118(1) :47 -51.
  • 7Chang JC,Hilsenbeck SG,Fuqua SA.Genomic approaches in the management and treatment of breast cancer.Br J Cancer,2005,92:618-624.
  • 8Taylor PJ,Burchell JM,Plunkett T,et al.MUC1 and the immunobiology of cancer.J Mammary Gland Biol Neoplasia,2002,7:209-221.
  • 9Soares MM,Mehta V,Finn OJ.Three different vaccines based on the 140-amino acid MUC1 peptide with seven tandemly repeated tumor-specific epitopes elicit distinct immune effector mechanisms in wild-type versus MUC1-transgenic mice with different potential for tumor rejection.J Immunol,2001,166:6555-6563.
  • 10Chen D,Xia J,Tanaka Y,et al.Immunotherapy of spontaneous mammary carcinoma with fusions of dendritic cells and mucin 1-positive carcinoma cells.Immunology,2003,109:300-307.

共引文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部